Reactive oxygen species and ovarian diseases: Antioxidant strategies

Reactive oxygen species (ROS) are mainly produced in mitochondria and are involved in various physiological activities of the ovary through signaling and are critical for regulating the ovarian cycle. Notably, the imbalance between ROS generation and the antioxidant defense system contributes to the development of ovarian diseases. These contradictory effects have critical implications for potential antioxidant strategies that aim to scavenge excessive ROS. However, much remains to be learned about how ROS causes various ovarian diseases to the application of antioxidant therapy for ovarian diseases. Here, we review the mechanisms of ROS generation and maintenance of homeostasis in the ovary and its associated physiological effects. Additionally, we have highlighted the pathological mechanisms of ROS in ovarian diseases and potential antioxidant strategies for treatment.

Automated summary

Reactive oxygen species (ROS) are produced in mitochondria and play a crucial role in regulating the ovarian cycle through signaling. However, an imbalance between ROS generation and the antioxidant defense system can lead to ovarian diseases. Understanding the mechanisms of ROS generation and homeostasis in the ovary, as well as the pathological effects and potential antioxidant strategies, is important for the development of effective treatments.